Successful preemptive therapy with single‐dose rituximab for Epstein‐Barr virus infection to prevent post‐transplant lymphoproliferative disease after pediatric hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Successful preemptive therapy with single‐dose rituximab for Epstein‐Barr virus infection to prevent post‐transplant lymphoproliferative disease after pediatric hematopoietic stem cell transplantation

Published:2019-10-15 Issue:6 Volume:21 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Kim Bo Kyung¹²,Kang Hyoung Jin¹²^ORCID,Hong Kyung Taek¹²,An Hong Yul¹²,Choi Jung Yoon¹²,Lee Jee Soo³,Park Sung Sup⁴,Shin Hee Young¹

Affiliation:

1. Department of Pediatrics Seoul National University College of Medicine Seoul Korea

2. Seoul National University Cancer Research Institute Seoul Korea

3. Department of Laboratory Medicine Hallym University Sacred Heart Hospital Anyang Korea

4. Department of Laboratory Medicine Seoul National University Seoul Korea

Funder

National Research Foundation of Korea

Seoul National University of Education

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13182

Reference33 articles.

1. Post-transplant lymphoproliferative disorders

2. Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

3. Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies

4. Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epstein–Barr Virus Monitoring after an Allogeneic Hematopoietic Stem Cell Transplant: Review of the Recent Data and Current Practices in Canada;Current Oncology;2024-05-14

2. Reactivation of cytomegalovirus, human herpes virus, and Epstein-Barr virus infections after hemapoietic stem cell transplantation in children;Journal Infectology;2024-01-11

3. Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative Disorder;Current Oncology Reports;2023-05-10

4. Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study;Haematologica;2022-09-22

5. Epstein-Barr virus: Biology and clinical disease;Cell;2022-09